Current approaches to enhancing oxime reactivator delivery into the brain
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG44__%2F19%3A00536978" target="_blank" >RIV/60162694:G44__/19:00536978 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/19:10400302
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S0300483X19301581" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0300483X19301581</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.tox.2019.05.006" target="_blank" >10.1016/j.tox.2019.05.006</a>
Alternative languages
Result language
angličtina
Original language name
Current approaches to enhancing oxime reactivator delivery into the brain
Original language description
The misuse of organophosphate compounds still represents a current threat worldwide. Treatment of poisoning with organophosphates (OPs) remains unsatisfactorily resolved despite the extensive investment in research in academia. There are no universal, effective and centrally-active acetylcholinesterase (AChE) reactivators to countermeasure OP intoxication. One major obstacle is to overcome the blood-brain barrier (BBB). The central compartment is readily accessible by the OPs which are lipophilic bullets that can easily cross the BBB, whereas first-line therapeutics, namely oxime-based AChE reactivators and atropine, do not cross or do so rather slowly. The limitation of oxime-based AChE reactivators can be ascribed to their chemical nature, bearing a positive charge which is essential either for their AChE affinity or their reactivating potency. The aim of this article is to review the methods for targeting the brain by oxime reactivators that have been developed so far. Approaches using prodrugs, lipophilicity enhancement, or sugar-based oximes have been rather unsuccessful. However, other strategies have been more promising, such as the use of nanoparticles or co-administration of the reactivator with efflux transporter inhibitors. Encouraging results have also been associated with intranasal delivery, but research in this field is still at the beginning. Further research of auspicious approaches is inevitable
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
<a href="/en/project/NV17-32801A" target="_blank" >NV17-32801A: Centrally acting antidotes for the treatment of organophosphorus poisoning</a><br>
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Toxicology
ISSN
0300-483X
e-ISSN
0300-483X
Volume of the periodical
423
Issue of the periodical within the volume
1
Country of publishing house
IE - IRELAND
Number of pages
9
Pages from-to
75-83
UT code for WoS article
000483417200006
EID of the result in the Scopus database
2-s2.0-85066068619